ITMO Santé Publique
ITMO Santé Publique
Date de modification : 01/01/2020 | Version : 2 | ID : 178
| Général | |
| Identification | |
| Nom détaillé | DEPRESSION – ANXIETY AND DISABIILTY IN A COHORT OF PATIENTS IN GENERAL MEDICINE PRACTICE |
| Sigle ou acronyme | DéPasS |
| Numéro d'enregistrement (ID-RCB ou EUDRACT, CNIL, CPP, etc.) | CNIL n° 909006 |
| Thématiques générales | |
| Domaine médical |
General practice Psychology and psychiatry |
| Mots-clés | depression, anxiety, functional disability, Sheehan, general practice, antidepressant |
| Responsable(s) scientifique(s) | |
| Nom du responsable | Crochard |
| Prénom | Anne |
| Adresse | 37-45 Quai du Président Roosevelt 92445 Issy-Les-Moulineaux |
| Téléphone | +33 (0)1 79 41 28 51 |
| acro@lundbeck.com | |
| Organisme | Lundbeck |
| Collaborations | |
| Financements | |
| Financements |
Private |
| Précisions | Lundbeck SAS Laboratory |
| Gouvernance de la base de données | |
| Organisation(s) responsable(s) ou promoteur | Lundbeck SAS |
| Statut de l’organisation |
Secteur Privé |
| Contact(s) supplémentaire(s) | |
| Caractéristiques | |
| Type de base de données | |
| Type de base de données |
Study databases |
| Base de données issues d'enquêtes, précisions |
Longitudinal study (except cohorts) |
| Origine du recrutement des participants |
A selection of health care professionals |
| Critère de sélection des participants |
Medication(s) taken |
| Le recrutement dans la base de données s'effectue dans le cadre d'une étude interventionnelle |
No |
| Informations complémentaires concernant la constitution de l'échantillon | Selection of general practitioners: Study investigators were randomly selected from a list of 30 000 general practitioners, which in turn was derived from an exhaustive list of all general practitioners licensed by the national medical association in France and in active practice (CEGEDIM registry). All physicians were contacted by mail and invited to participate in the study. Selection of patients: each participating GP included around four eligible patients who spontaneously consulted for an anxiety or mood disorder during the three months following receipt of the study materials. |
| Objectif de la base de données | |
| Objectif principal | To evaluate the change in self-reported personal, professional and social disability in patients with anxious or mood disorders three months after initiating antidepressant treatment. |
| Critères d'inclusion |
Patient of at least 18 years of age
Patient having at least one of the 5 following diagnoses: major depressive episode (i.e. characterized) Generalized anxiety disorder Social anxiety disorder Panic disorder with or without agoraphobia Obsessive compulsive disorders Patient initiating a new treatment with an antidepressant Patient being able to communicate and to evaluate his quality of life Patient having received written information on the use of the medical data concerning himself within the framework of the study. |
| Type de population | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population concernée |
Sick population |
| Sexe |
Male Woman |
| Champ géographique |
National |
| Détail du champ géographique | Metropolitan France |
| Collecte | |
| Dates | |
| Année du premier recueil | 2009 |
| Année du dernier recueil | 2010 |
| Taille de la base de données | |
| Taille de la base de données (en nombre d'individus) |
[1000-10 000[ individuals |
| Détail du nombre d'individus | 8 029 |
| Données | |
| Activité de la base |
Data collection completed |
| Type de données recueillies |
Clinical data Declarative data |
| Données cliniques, précisions |
Direct physical measures |
| Données déclaratives, précisions |
Paper self-questionnaire |
| Existence d’une biothèque |
No |
| Paramètres de santé étudiés |
Health event/morbidity Quality of life/health perception |
| Modalités | |
| Mode de recueil des données | Data collection was carried out at each visit on a voluntary and anonymous basis.Data were collected at the index consultation (inclusion visit) and at two follow-up consultations about 6 and 12 weeks after the index consultation. A window of ±2 weeks was considered acceptable for the 6-week visit and a window of ±3 weeks for the 12-week visit. These visits were programmed as part of the routine follow-up of the patients, and no additional protocol-specified study visit was imposed. Patients' disbility was evaluated with the Sheehan Disability Scale (SDS) at baseline and after six and twelve weeks.The patient's symptomatology was also filled in by the patient himself using the HAD self-questionnaire at each of three collection times scheduled in the protocol.Other data were collected by the physician himself. |
| Suivi des participants |
Yes |
| Détail du suivi | 3 months |
| Appariement avec des sources administratives |
No |
| Valorisation et accès | |
| Valorisation et accès | |
| Lien vers le document | http://tinyurl.com/Hal-DEPASS |
| Description | List of publications in HAL |
| Lien vers le document | http://tinyurl.com/Pubmed-DEPASS |
| Description | List of publications in Pubmed |
| Accès | |
| Charte d'accès aux données (convention de mise à disposition, format de données et délais de mise à disposition) | Publication in progress |
| Accès aux données agrégées |
Access on specific project only |
| Accès aux données individuelles |
Access on specific project only |
| A PROPOS | CATALOGUE | RESSOURCES | LIENS UTILES
|  Ce site respecte les principes de la charte HONcode. Vérifiez ici. |
8 rue de la Croix Jarry 75013 Paris Tél: 01 44 23 67 47 |
Partenaires - F.A.Q. - Contact - Plan du site - Mentions légales - Administration - PEF-HD - Mis à jour le 15 décembre 2020 - Version 4.10.05
